Bing Li

Dr. Bing Li


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJing Li
Jing Li
ZSZhaoRong Shi
ZhaoRong Shi
ZWZhen Wang
Zhen Wang
ZLZhibing Liu
Zhibing Liu
XWXinhu Wu
Xinhu Wu
JLjing li
jing li
CyberKnife (CK) is a novel stereotactic radiosurgery system for treating tumors in any part of the body. It is a non-invasive or minimally invasive tumor treatment modality that can deliver high doses of spatially precise radiation and minimize exposure to neighboring healthy tissues or vital organs. The purpose of this study was to investigate the safety and efficacy of CK in the treatment of adrenal tumors. We performed a retrospective analysis of 26 patients with adrenal tumors who had been treated with CK in the radiotherapy center of our hospital between March 2009 and March 2012. Eight patients had primary adrenal tumors and 18 patients had metastatic adrenal tumors. In addition to CK, 4 patients received chemotherapy and 2 patients received immunotherapy. The average tumor volume was 72.1 cm3 and the prescribed radiation dosage ranged from 30 to 50 Gy and was fractionated 3 to 5 times with a 58% to 80% isodose line. Abdominal CT was performed between 1 to 3 months after the CK treatment to evaluate the short-term efficacy with follow-up examinations once every 3 months. Three patients had complete remission, 12 patients had partial remission, 5 patients had stable disease, and 6 patients had progressive illness. The effective rate of pain relief was 93.8% and the disease control rate was 77% with a median overall survival of 17 months and a median progression-free survival of 14 months. Treatment Related toxicity was well-tolerated, but preventative measure need to be taken for radiation enteritis. CK is safe and effective for treating adrenal tumors with few adverse reactions. Nonetheless, its long-term effects requires further follow-up.

1 January 2013 in World Journal of Radiology
Verified
Journal Article
Open access
JMJun Meng
Jun Meng
YDYong Du
Yong Du
HYHan Feng Yang
Han Feng Yang
FHFu-Bi Hu
Fu-Bi Hu
YHYa-Yong Huang
Ya-Yong Huang
CZChi-Shing Zee
Chi-Shing Zee
Thoracic epidural angiolipoma: A case report and review of the literature

7 July 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
YLYang Li
Yang Li
CYChao Feng Yang
Chao Feng Yang
JPJun Peng
Jun Peng
BLBing Li
Bing Li
CZChuan Zhang
Chuan Zhang
JYJin Hong Yu
Jin Hong Yu
Background: The diagnostic accuracy of computed tomography (CT)-guided percutaneous core needle biopsy (CNB) for small (≤ 20 mm) ground-glass opacity (GGO) lesions has not been reported in detail. Objectives: To evaluate factors that affect the diagnostic accuracy of CT-guided percutaneous CNB for small (≤ 20 mm) GGO pulmonary lesions. Methods: From January 2014 to February 2018, 156 patients with a small (≤ 20 mm) GGO pulmonary lesion who underwent CT-guided CNB were enrolled in this study. Factors affecting diagnostic accuracy were evaluated by analyzing patient and lesion characteristics and technical factors. Significant factors were identified by multivariate logistic regression. Results: The diagnostic accuracy of CT-guided percutaneous CNB was 90.4% for small (≤ 20 mm) GGO pulmonary lesions. The diagnostic accuracy was higher for larger lesions (72.5% for lesions ≤ 10 mm, 96.6% for lesions between 11 and 20 mm [P < 0.001]). The diagnostic accuracy of CT-guided percutaneous CNB was 74.5% for lesions with > 90% GGO components and 97.2% for lesions with 50–90% GGO components (P < 0.001). In multivariate analysis, the significant factors influencing diagnostic accuracy were lesion size (P = 0.022; odds ratio [OR] for a lesion between 11 and 20 mm in size was approximately 5 times higher than that for a lesion ≤ 10 mm; 95% confidence interval [CI], 1.3 to 18.5), and GGO component (P = 0.015; OR for a lesion with 50–90% GGO components was approximately 6 times higher than that for a lesion with > 90% GGO components; 95% CI: 1.4 to 25.7). Conclusions: Lesion size and GGO component are factors affecting diagnostic accuracy. The diagnostic accuracy was higher for larger lesions and lesions with 50–90% GGO components.

1 April 2014 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
JYJin Hong Yu
Jin Hong Yu
YDYong Du
Yong Du
YLYang Li
Yang Li
HYHan Feng Yang
Han Feng Yang
XXXiao Xue Xu
Xiao Xue Xu
BLBing Li
Bing Li

1 January 2024 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
CZChuan Zhang
Chuan Zhang
JSJing Shi
Jing Shi
BLBing Li
Bing Li
XYXiaoxuan Yu
Xiaoxuan Yu
YDYong Du
Yong Du
HYHan Feng Yang
Han Feng Yang
With a gradual increase in breast cancer incidence and mortality rates and an urgent need to improve patient prognosis and cosmetology, magnetic resonance imaging (MRI)-guided radiofrequency ablation (RFA) therapy has attracted wide attention as a new treatment method for breast cancer. MRI-RFA results in a higher complete ablation rate and extremely low recurrence and complication rates. Thus, it may be used as an independent treatment for breast cancer or adjuvant to breast-conserving surgery to reduce the extent of breast resection. Furthermore, with MRI guidance, accurate control of RFA can be achieved, and breast cancer treatment can enter a new stage of minimally invasive, safe, and comprehensive therapy. With progress in MR thermometry technology, the applications of MRI are expected to broaden.

1 April 2013
Verified
Journal Article
Closed access
BLBing Li
Bing Li
YDYong Du
Yong Du
HYHan Feng Yang
Han Feng Yang
YHYayong Huang
Yayong Huang
JMJun Meng
Jun Meng
DXDongmei Xiao
Dongmei Xiao